| http://www.w3.org/ns/prov#value | - re can be used to inhibit the release of TNF??.It is therefore an object of this invention that the compounds of formula 1 and their salts, as well as pharmaceutical preparations, which contain these compounds or their salts, can be used for the treatment of illnesses, for which an inhibition of TNF?? is useful.These illnesses include, for example, inflammation of the joints, including arthritis a
|
